| Cat. No. |
Product Name |
Information |
| PC-45781 |
L-165041
|
A selective PPARδ agonist with Ki of 6 nM, >120 fold selectivity over PPARγ. |
| PC-45908 |
Troglitazone
|
A PPARγ activator that has antidiabetic, anti-tumor and anti-inflammatory activities. |
| PC-44047 |
Choline Fenofibrate
|
A PPARα agonist used for treatment of hyperlipidemia. |
| PC-45176 |
Fenofibrate
|
A PPARα agonist that exhibits EC50 of 18 and 30 uM for murine and human PPARα, respectively, in a transactivation assay. |
| PC-44663 |
CDDO-Im
|
A potent Nrf2 activator that elevates protein levels of Nrf2 and induces Nrf2/ARE signaling. |
| PC-42713 |
GW 501516
|
A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay. |
| PC-45209 |
Rosiglitazone
|
A potent and selective PPARγ agonist that binds to the PPARγ ligand-binding domain with a Kd of 40 nM. |
| PC-42693 |
BMS-687453
|
A potent and selective PPARα agonist with EC50 of 10 nM for human PPARα and 410-fold selectivity over human PPARγ in PPAR-GAL4 transactivation assays. |
| PC-44041 |
Aleglitazar
|
A potent and balanced dual PPARα/γ agonist (EC50= 50/21 nM). |
| PC-45753 |
Saroglitazar magnesium salt
|
A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively. |
| PC-45752 |
Saroglitazar
|
A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively. |
| PC-45067 |
Elafibranor
|
A nove, potent dual PPAR α/δ agonist with EC50 of 45 and 175 nM, respectively. |
